The scientific advances on phytochemistry, antinociceptive and anti-inflammatory activities from Cleomacea family are described. A systematic review was performed according to PRISMA statement. A search of scientific literature was performed in specialized database (Scopus, Science Direct, PubMed, Google Scholar) to obtain information and Iltis & Cochrane taxonomic classification was employed. Some genus (Cleome, Corynandra, Gynandropsis, Cleoserrata, Tarenaya) are widely used in traditional medicine for treatment of inflammatory diseases (rheumatic and skin diseases), fever, malaria and diabetes, and its polar extracts have been described as anti-inflammatory and antinociceptive agents. C. rutidosperma, C. arabica, C. viscosa and C. droserifolia showed in vitro immunomodulador activity in macrophages and PMN. Also, T. spinosa, C. chelidonii, C. arabica, C. viscosa, C. rutidosperma and G. gynandra have shown antiinflammatory activity an in vivo carrageenan and chronic inflammation AFC models. Only, from C. droserifolia and C. viscosa anti-inflammatory compounds have been isolated and were identified as flavonoids and cumarinolignoids. Others compounds isolated from these plants are steroids, phenolic acids, anthocyanins, terpenes, and alkaloids, but some of these compounds still have not been investigated; in addition, the essential oils from C. amblyocarpa, C. rutidosperma, C. viscosa, T. spinosa and C. chelidonii have significative antinociceptive activity; this effect was comparable to morphine, aspirine, diclofenac, dipyrone or pentazocine. Cleomaceae family is a potential source of active principles that will allow the development of new therapeutic alternatives for the treatment of diseases in which an inflammatory process and/or pain occurs.
INTRODUCTION
Family Cleomaceae are described in the taxonomy catalogs by Iltis & Cochrane (Iltis and Cochrane, 2014a) , and includes some genus such as: Andinocleome Iltis & Cochrane, Podandrogyne Ducke, Mitostylis Raf., Physostemon Mart. & Zucc., Tarenaya Raf. (Iltis and Cochrane 2014b) , Cleoserrata Iltis, Hemiscola Raf., Peritoma DC. (Iltis and Cochrane 2007; Neto et al., 2017) , Corynandra Schrad. Ex Spreng. (Cochrane and Iltis, 2014) Polanisia Raf, Gynandropsis DC., Cleome L., with 270 species, which are small trees, herbs or shrubs and have cosmopolitan distribution, although are more abundant in tropical and subtropical regions (Iltis and Cochrane, 2014a) . This family was previously grouped as a subfamily Capparaceae (Pax and Hoffmann, 1936) . However, phylogenetic and molecular studies, allowed it to demonstrate its monophyly and phylogenetic relationship with the family Brassicaceae (Hall et al., 2002; Hall, 2008; Iltis et al., 2011) .This family has problems in taxonomic classification because of the generic boundaries and geographical distribution among species from the New World (America) and Old World (mostly in Africa, India and the Middle East), leading to the generic segregation of some genus (Cochrane and Iltis, 2014) . However, molecular data and morphological analysis were needed to support changes in the taxonomy of this family (Patchell et al., 2014) . In recent years, several studies have focused on the precise identification of the species and attempts have been made to reconstruct the phylogenetic origin of this family by analyzing the genetic regions of chloroplasts and mitochondria using DNA sequence analysis and internal transcribed spacer of the DNA (ITS) region of the nuclear ribosomal DNA (rDNA) (Hall, 2008; Patchell et al., 2014; Feodorova et al., 2010; Tamboli et al., 2016) . The Cleomaceae family is important for research on floral morphogenesis evolution (Bhide et al., 2014) , Cleomaceae is a model to study C3-C4 photosynthetic pathway, phylogenetic origins (Feodorova et al., 2010) pollination ecology importance (for the study of self-and cross-pollination through polymorphism) (Machado et al., 2006) , climate resilient species suitable for the ecological restoration (Raju and Rani, 2016) . One of the genera with the highest number of species and widely used in traditional medicine is Cleome, which has been divided recently into two segregated genus: Corynandra Schrad. ex Spreng and Cleoserrata (Jacq.) Iltis (Iltis and Cochrane, 2007; Neto et al., 2017) . The name Corynandra was first used by Schrader (1825) and subsequently Rafinesque (1838) proposed the name Arivela Raf. The latter name has been used in some floristic catalogs (Zhang and Tucker, 2008; Tucker and Vanderpool, 2010; Acevedo-Rodríguez and Strong, 2012) ; however, Corynandra is the first legitimate name (Cochrane and Iltis, 2014) .
In countries from Africa and Asia, some wild or semidomesticated species of the Cleomaceae family are used as medicinal plants in health systems and as a nutritional supplement (Schönfeldt and Pretorius, 2011 ). An ethnobotanical study performed by Ahouansinkpo et al. (2016) describes that the leaves of Gynandropsis gynandra (L.) Briq (Syn. Cleome gynandra L.) and Corynandra viscosa (L.) Cochrane & Iltis (Syn. Cleome viscosa L.) are consumed as vegetables in the locality of Benin, located in West Africa; in addition, G. gynandra is used as food by 70% of those interviewed and 38% described that this specie is used as medicinal plant; while C. viscosa is more widely used in traditional medicine by 45% of those interviewed (Ahouansinkpo et al., 2016) . Some species (Table 1) are used in traditional medicine to treat diseases in which there is an inflammatory process, such as rheumatic diseases, earaches, stomach pain, fever and skin wounds. It is well known that natural products have been a main source of Adv Med Plant Res 108 therapeutic alternatives and it has been reported in the scientific literature that some species of the family Cleomacea have important pharmacological activities such as: antioxidant, analgesic (antinociceptive), antiinflammatory, antipyretic, antimicrobial, anticancer, and others (Djeridane et al., 2010; Bose et al., 2007; Bose et al., 2011; Ranjitha et al., 2014; Tigrine et al., 2013) . Inflammation is defined as a process of defense of vascularized tissues, in which the immune system is activated to eliminate, destroy or isolate the noxious stimulus (injuries due to trauma, irritants, infection by microorganisms or parasites (Ashley et al., 2012) . This process involves early vascular changes due to the release of molecules by inflammatory cells and those found at the site of the injury, allowing an increase in vascular permeability and the blood flow that facilitates the infiltration of cells such as polymorphonuclear lymphocytes (PMN) and macrophages (innate immune response); they generate the characteristic signs of local inflammation: heat, redness, pain, swelling and loss of function. If the stimulus is persistent and the defensive capacity of the innate immune system is exceeded, they lead to the activation of a more specialized response (adaptive immune response) as performed by T lymphocytes, plasma cells that produce antibodies. During the inflammatory process proinflammatory cytokines such as Tumor Necrosis Factor (TNF-α), interleukin 1β (IL-1β), interleukin 6 (IL-6) are released, involved in the initiation and maintenance of inflammatory responses. In this process, other molecules also are generated that allow the elimination of antigens that have been phagocytosed, such as nitric oxide (NO), catalyzed by inducible nitric oxide synthase (iNOS) in macrophages (Mittal et al., 2014) . If the inflammatory process is prolonged, inefficient or there is deregulation of the mechanisms, this progresses to a chronic inflammation which can generate damage to the tissues of the host. Chronic inflammation is associated with cardiovascular diseases, cancer and rheumatic conditions such as rheumatoid arthritis (RA), lupus and osteoarthritis (OA) (McInnes and Schett, 2011) .
In a tissue with injury or damage, the inflammation can generate peripheral sensitization in the environment close to sensory nerve fibers (nociceptors); this condition can cause pain, due to chemical changes generated by the accumulation of inflammatory molecules released by cells such as mast cells, basophils, platelets, macrophages, neutrophils, endothelial cells and fibroblasts. The nociceptors express one or more cell surface receptors that can respond to each of these proinflammatory molecules (Basbaum et al., 2009) . For example, bradykinin is a vasodilator that acts by binding to receptor B2 (RB2), which activates phospholipase C and the production of second messengers to elevate intracellular Ca 2+ to sensitize nociceptors (Brown and Passmore, 2010) .The arachidonic acid generated by the cyclooxygenase (COX) enzymes, as well as (Edziri et al., 2013) Aerial parts cleomblynol A (1) cleomblynol B cleocarpanol (2) cabraleahydroxy lactone (3) amblyone (4) isocleomblynol A luteolin 3'-methyl ether luteolin 3'-methyl ether 7-glucoside (Harraz et al., 1995) Whole plant 17α-hydroxycabraleahydroxylactone (5)
12β-acetoxy-Δ (Ismail et al., 2005) Aerial parts (17-(4-hydroxy-1,5-dimethylhexyl)-2,3,7-(acetyloxy) gona-1,3,5(10)-trien-15-ol) (25) ( (Fushiya et al., 1999) 
cleomeside A and cleomeside B (69 and 70) prostaglandins E 2 (PGE 2 ), induces an increase in cyclic adenosine monophosphate (cAMP) and directly stimulates the nociceptor (Pitchford and Levine, 1991) . Some proinflammatory cytokines such as IL-1β, IL-6 y TNF-α are involved in the process of pathological pain. IL-1β increases the production of substance P and PGE 2 in neuronal and glial cells. IL-6 is involved in the regulation of the expression of neuronal neuropeptides and contribute to the development neuropathic pain by nerve injury. The cytokine TNF-α, through TNF-receptors cell surfaces, can participate in inflammatory hyperalgesia, as in neuropathic (Zhang and An, 2007) .
In this paper, we describe the pharmacological potential (specifically anti-inflammatory and antinociceptive properties), as well as the phytochemical research through the analysis of information published in sources such as PubMed, Scopus, Science Direct, Google Scholar for some species of the Cleomaceae family.
METHODS
The systematic review was performed according to the PRISMA statement (Moher et al., 2015) . The information from articles and books was obtained from 1980 until February 2018 and was obtained from different scientific database (Scopus, Science Direct, PubMed, Google Scholar), we found 93 articles and 7 books. The following English and Spanish keywords were used to search for the academic information: anti-inflammatory activity, antinociceptive activity, genus Cleomaceae family, chemical composition, immune system, pain. The articles were stored in a digital folder according to the year and the subject, were reviewed by two independent investigators. The criteria for the selection of reports in this review were as follows: i) information the genus belonging to the family Cleomaceae, using the accepted scientific name in specialized database and its synonyms; ii) Information describes the scientific evidence on anti-inflammatory and antinociceptive activities from Cleomaceae family, iii) Information describes chemical composition of some genus from the Cleomaceae family. The thesis book was excluded. The taxonomic classification was done in according to the Iltis & Cochrane. The scientific names of the species were consulting Missouri Botanical Garden (http://www.tropicos.org) and The Plant List (2013). Version 1.1. (http://www.theplantlist.org/).
RESULTS

In vitro anti-inflammatory activity from some species of the Cleomaceae family
The scientific literature has described that some species of this family have activity on cells of the immune system (immunomodulator activity), such as macrophages and PMN and generate inhibition of molecules involved in the inflammatory process. Ding et al. (2016) reported that the EtOH extract (95%) of Cleome rutidosperma DC. inhibited the expression and production of proinflammatory mediators in macrophages from central nervous system (murine microglial cell line, BV-2), stimulated with lipopolysaccharides (LPS). At concentrations of 0.05 and 0.1 mg/ml, it inhibits NO production in LPS-activated BV-2 cell by attenuated expression of the iNOS enzyme. It attenuates mRNA production and expression of COX-2. In addition, it inhibits levels of IL-6, TNF-α and suppresses the transcriptional activity of IL-1β and the chemokine CCL2/MCP-1 or monocyte chemoattractant protein and increases the expression of antioxidant enzymes such as hemo-oxygenase, glutamate cysteine ligase and quinone oxidoreductase. The authors propose that the antiinflammatory activity of this extract is due to the inhibition of the nuclear transcriptional factor kappa B (NF-κB), through sub-regulation of the phosphorylation of p65 and by modulation of the activation of the amino terminal kinase of c-Jun (JNK).
On the other hand, in neutrophils (isolated from healthy individuals) was stimulated with different concentrations (0.1, 1, 10 or 100 μM) of the calcium ionophore (A23187), the release of leukotriene B4 (LTB4) and the production of PGE 2 can be induced. In this model, the MeOH (70%) extract from Cleome arabica L. leaves at 25 μg/ml inhibits the release of LTB 4 over all tested concentrations of ionophore A23187; but at the concentration 100 μM of the A23187 ionophore (maximum production of LTB4); the C. arabica extract (25 μg/ml) reduced the production of LTB4 by 25% compared to rutin and quercetin (25 μM); these two flavones showed 35 and 95% inhibition, respectively. In addition, the extract at 25 μg/ml and rutin at 25 μM increased the production of PGE 2 in the presence of the calcium ionophore at 1 and 10 μM. Also, this extract inhibited 26.1% of the PGE 2 production when the calcium ionophore (A23187) was tested at 100 μM and quercetin inhibited the PGE 2 production at concentrations of 1-100 μM of A23187 (Bouriche et al., 2005) . These same authors describe that the MeOH (70%) extract inhibited the soybean lipoxygenase; in this case, the extract showed an inhibitory concentration medium (IC 50 ) = 10 μg/ml, while rutin and quercetin (the positive control) showed an IC 50 = 11 and 14 μM, respectively.
In the inflammatory process, among the first cells to migrate and accumulate in tissue with injury or damage are PMN lymphocytes, which release proteolytic enzymes capable of eliminating pathogens; but their prolonged activity can damage tissues. A yellow precipitate obtained from the MeOH (70%) extract of the leaves of C. arabica was evaluated on the migration of PMN isolated from the blood of healthy donors using as Juárez-Vázquez and Jiménez-Arellanes 121 chemotactic factor N-formyl-L-methionyl-L-phenylalanine in a chemotaxis chamber. The percentage of neutrophil inhibition was 83.9% at extract concentration of 50 μg/ml and the reference drug (aspirin) at 50 μM showed 66.23% inhibition (Bouriche et al., 2003) . Pillai and Nair (2014) reported that the MeOH and CHCl 3 extracts from C. viscosa (L.) Cochrane & Iltis and C. burmanni Wight & Arn. inhibited protein denaturation in the albumin assay, as well as proteinase inhibitory activity and the inhibition of hyaluronidase in vitro. In chronic inflammation, these processes are involved in the contribution to tissue damage. In the albumin denaturation test, the MeOH extract of C. viscosa at 0.8 mg/ml inhibited the protein denaturation with 88.92% and the CHCl 3 extract had an inhibition of 59.75%, while aspirin at the same dose inhibited 95.82%. In addition, the MeOH and CHCl 3 extract from C. burmanni, had a lower activity, with 78.92 and 50.42% inhibition, respectively, in the same model. The MeOH extract of C. viscosa at a concentration of 0.6 and 0.8 mg/ml showed the best activity in the proteinase inhibition assay with values of 59.70 and 78.26 %, respectively, while aspirin at 0.6 and 0.8 mg/ml showed 64.44 and 88.20% of the inhibition. The MeOH extract of C. viscosa and C. burmanni (0.8 mg/ml) inhibited the hialorunidase activity with 82.11 and 70.89%, respectively; these values were similar to indomethacin (0.8 mg/ml) with 91.33%.
In vivo anti-inflammatory activity of some genus of the Cleomaceae family
One of the main models used for the discovery of nonsteroidal anti-inflammatory drugs (NSAIDs) such as indomethacin is the murine model of plantar edema induced with carrageenan, which increases the volume of the animal's paw (Winter et al., 1963) . In this model, the edema is generated in two phases; in the first phase (1-2 h), vasoactive amines (histamine, serotonin, bradykinin) are released and in the last phase (3-5 hours), the COXactivity is observed. In addition, there is a local infiltration of neutrophils that contributes to the production of reactive species; also, the release of NO is generated (Salvemini et al., 1996) . In this last phase, NSAIDs, COX-2 inhibitors and monoclonal antibodies directed to PGE 2 are effective (Cong et al., 2015; Portanova et al., 1996) . Some species belonging of Cleome, Corynandra, Gynandropsis and Tarenaya genus have shown a significative anti-inflammatory effect. For example, the MeOH extract from leaves collected in the wild and produced by biotechnological process from the Tarenaya spinosa (Jacq.) Raf. (Syn. Cleome spinosa Jacq.), was tested on carrageenan model at doses between 1 to 50 mg/kg, administered intraperitoneally (i.p.). Both extracts (from biotechnological material and wild) have antiinflammatory activity, showed edema inhibition between 40 and 50% on the 3rd hour with respect to the reference drug (indomethacin, 10 mg/kg, i.p., 55 to 60%) (Albarello et al., 2013) .
On the other hand, the MeOH extract from Corynandra chelidonii (L. f.) Cochrane & Iltis ex Spreng. (Syn. Cleome chelidonii L.f.) whole plant was tested on the carrageenan model at dose of 200 mg/kg administrated by intragastric route (i.g), showed an inhibition of 54.6% of the edema, with respect to the reference drug aspirin (10 mg/kg, i.g), which inhibited 60.6% at 3 h (Parimalakrishnan et al., 2007) .
The MeOH extract, CHCl 3 fraction and ethyl acetate fraction of C. viscosa were tested at a dose of 50 mg/kg/i.g in the carrageenan model, obtaining at 4 h, a significant anti-inflammatory activity being of 66.67, 89.33 and 100% of inhibition, respectively; this effect was similar to indomethacin 100% (at 10 mg/kg) (Khanam et al., 2015) . On the other hand, the MeOH extract was evaluated against carrageenan-histamine and dextraninduced rat paw edema. The results were similar compared to the reference diclofenac sodium (20 mg/kg) (Parimala et al., 2003) .
The MeOH extract (70%) of C. arabica leaves possesses anti-inflammatory activity in carrageenaninduced rat paw edema; at 100, 200 and 300 mg/kg, it reduced the edema formation with 34.46, 42.14 and 58.46%, respectively, when was administered by i.g at 5 h. This extract showed ED 50 = 231 mg/kg and aspirin at 100 mg/kg with 73.63 % inhibition of edema (Bouriche et al., 2003) . The EtOH extract (200 and 400 mg/kg/i.g. via) and the diethyl ether, ethyl acetate and n-butanol fractions from the aerial parts of C. rutidosperma at 200 mg/kg showed anti-inflammatory activity in the carrageenan model at the 3rd hour. The EtOH extract at a dose of 200 mg/kg reduced the volume (0.44 ml) and the three fractions showed values between 0.39 and 0.44 ml, with respect to diclofenac control (12.5 mg/kg), it which showed a reduction of 0.31 ml (Bose et al., 2007) . However, the same extract at doses of 200 and 400 mg/kg by i.g and the same fractions at 200 mg/kg by i.g also showed inhibitory activity in the chronic inflammation model (arthritis induced by Freund's complete adjuvant-ACF) in rats; the samples were administered during 30 days. In this assay, the extract at 400 mg/kg reduced the size of the edema with 0.48 ml, the fractions at 200 mg/kg reduced the size of the edema with values between 0.44 and 0.60 ml, the effect of the extract and fractions was lower with respect to the reference drug diclofenac (12.5 mg/kg) with 0.41 ml (Bose et al., 2007) .
In AFC model, the histopathological analysis of the hind limbs from arthritic rats generated an increase in paw volume, with alteration in tissue architecture, also showing synovial hyperplasia, monomorphonuclear and polymorphonuclear cell accumulation in the joint space. Narendhirakannan et al. (2005) described that the EtOH 95% extract from G. gynandra leaves at 150 mg/kg/i.g. during 30 days in rat showed an anti-inflammatory activity; in this assay the edema volume decreased from Adv Med Plant Res 122 the third week of treatment with the highest activity in the fourth week with significative reduction of inflammatory exudates. Subsequently, in 2007 the same author reported that in the plasma of the arthritic rat, showed an increase of TNF-α levels and in the liver tissue an increase of alkaline phosphatase, aspartate aminotransferase, alanine aminotransferase, captesin-D, β-glucuronidase, N-acetyl-β-glucosaminidase, lactate dehydrogenase and glycoproteins. This specie showed a significant anti-inflammatory activity in acute and chronic models; therefore, it is necessary to carry out additional studies that confirm its pharmacological activity and allow the isolation and chemical identification of the active principles.
Phytochemistry and anti-inflammatory activity of the pure compounds isolated from genus of the Cleomaceae family
From organic extracts of the whole plant, stems, flowers, roots, seeds and leaves of some species of the Cleomaceae family several secondary metabolites have been reported by qualitative analysis tests, such as: polyphenols, flavonoids, coumarins, quinones, carbohydrates/glucosides, alkaloids, steroids, saponins, terpenes among others, without chemical identification for each component (El-Wahab et al., 2016; Singh et al., 2017; Alamilla-Fonseca et al., 2018) . On the other hand, Table 1 describes the main metabolites isolated from Cleome, Corynandra, Gynandropsis and Tarenaya genus. In Table 2 , we describe the main components from essential oils by Cleome, Corynandra, Tarenaya and Cleoserrata.
The main metabolites that biosynthesize the species of Cleomaceae family are phenolic compounds. Sharaf et al. (1992) , and Wollenweber et al. (2007) reported polymethoxyflavonols, glucoflavonoids, flavanones and their glycosides for genus Cleome and bioactive cumarinolignoids have been described for Corynandra genus.
From MeOH extract of Cleome droserifolia (Forssk.) Delile aerial parts, two active flavonoids identified as 5,4 'dihydroxy-6,7,8,3',5'-pentamethoxyflavone (32) and 5,4'dihydroxy-6,7,8,3'-tetramethoxyflavone (8methoxycirsilineol, 33) were isolated and reduced the NO production in peritoneal macrophages induced with the Bacillus Calmette-Guerin and stimulated with LPS. Compound 32 inhibited the production of NO by 60% at 10 μg/ml; it was more active than genistein (positive control), and suppresses NO production by 41% at 20 μg/ml, and compound 33 was less active. A correlation was observed between NO production and cell viability RAW 236.7 murine macrophages stimulated with LPS. Compounds 32 and 33 in a range of 0 to 20 μg/ml inhibited NO production, with IC 50 = 50.5 and 85.5 μM, respectively, while genistein showed an IC 50 = 9.6 μM Table 2 . Main chemical constituents of the essential oil from some species of the Cleomaceae family.
Species
Part used Main constituent essential oils References
Whole plant 24(s)-ethyl-3-α,5-α-cyclocholest-22(E)-en-6-one (19.29%); Δ-4sitosterol-3-one (14.75%); cholest-4-en-3-one (12.35%); stigmasta-5, 23-dien-3-ol,(3-β) (12.17%); neophytadiene (6.83%); hexatriacontane (6.22%); 1-alanine, N-(3-fluorobenzoyl)-undec-10enyl ester (5.96%); phytol (5.67%); tetracontane (4.30%); 1,2benzenedicarboxylic acid (3.25%) Pillai and Nair (2013) Cleome droserifolia (Forssk.) Delile Aerial parts E)-3,7,11-trimethyl-1,6,10-decatrien (11.8%); carotol (10.1%); δcadinene (8.9%); β-eudesmol (7.0%); benzyl isothiocyanate (5.9%) Muhaidat et al. (2015) Cleome heratensis Bunge & Bien. ex Boiss.
Aerial parts Hexanal (7.57%-33.96%), α-phellandrene (6.08% -13.17%), αfarnesen (7.54%-10.9%), methyl eugenol (6.74%-8.31%), eugenol (3.94%-7.4%), verbenone (3.98%-6.24%), myrcene (1.54%-5.75%), hexadecane (2.34%-4.82%), linalool (1.59% -3.53%), α-humulene (1.01%-1.93%) Nasseri et al. (2017) Cleome iberica DC. Aerial parts Carotol (21.8%), germacrene D (15.8%), β-cubebene (15.5%), trans-nerolidol (5.6%), δ-cadinene (4.5%) hexyl acetate (4.0%). Mirza et al. (2005) Cleome monophylla L.
Aerial parts Terpenolene (14%),1-α-terpeneol (10%), pentacosane (9%), (α + β)humulene (8%), phytol (5%), 2-dodecanone (4%) Ndungu et al. (1995) Cleoserrata serrata (Jacq.) Iltis (Syn. 
Aerial parts without
Caryophyllene oxide (10.5%), (-)-spathulenol (7.5%), Z-phytol (6.9%) Flowers 7-alpha-hydroxy manool (23.8%), incensole (9.2%) sclareol (8.7%)
Fruits
Tetradecanoic acid (40.6%), (Z)-phytol (6.58%), sclareol (4.5%) Leaves (Z)-phytol (19.5%), 7-α-hydroxy manool (6.8%), caryophyllene oxide (4.36%) (Fushiya et al., 1999) . The mixture of cleomiscosins A-C (85-87) obtained from the MeOH extract of C. viscosa seeds inhibited the production NO, modulated pro-inflammatory and antiinflammatory cytokines in vivo and in vitro model. For example, in mice healthy were administered the cleomiscosins mixture at 10, 30 and 100 mg/kg/day (solubilized in carboxymethylcellulose at 0.5%, and administerd by i.g. via) for 14 consecutive days; after that, peritoneal macrophages and spleenocytes were isolated. In supernatant culture from the mouse peritoneal macrophages stimulated with LPS (1 μg/ml) increased IL-6, TNF-α and NO expression; the mixture of cleomiscosins at 10 and 30 mg/kg decreased the ON levels with values of 122.51 and 129.23 nM/ml, respectively, compared with LPS control-macrophages 312.31 nM/ml. Also, the pro-inflammatory mediator IL-6 in LPS-macrophages control increased (2033.67 pg/ml); however, the cleomiscosin mixture at 10 mg/kg decreased the IL-6 values (1067.58 pg/ml). Likewise, the cleomiscosin mixture at 10 and 30 mg/kg inhibited the production TNF-α in culture with values of 286.87 and 299.06 pg/ml, respectively, with respect to LPSmacrophage control (430.97 pg/ml) (Bawankule et al., 2008) . In murine spleenocytes stimulated with Concavalin A (Con-A,5 μg/ml), the expression level of IL-4 in supernatant culture was 235.47 pg/ml, and the cleomiscosin mixture at 10 mg/kg increased the production of IL-4 with values of 327.50 pg/ml. These authors carried out an additional study to confirm the expression of pro-inflammatory mediators (TNF-α and IL-6) in serum and acute toxicity using an in vivo model treated with LPS (250 µg/kg), which induced lethal toxicity. The cumarinolignoids A-C was administered by i.g via at 10 and 30 mg/kg during 14 days; after the last administration the mice were injected LPS. The mixture of compounds inhibited the production of proinflammatory mediators, also reduced the animal mortality in dose dependent manner (Bawankule et al., 2008) .
The quercetin-3-O-(2''-acetyl)-glycoside (85) isolated from the 85% MeOH extract of C. viscosa fresh flowers at a dose of 100 and 200 mg/kg administered by i.p. via showed anti-inflammatory activity with 51.7 and 45% inhibition in the second phase (3 h) on the carrageenan model; the effect was compared to phenylbutazone at 100 mg/kg/i.p. via with 70% inhibition (Senthamilselvi et al., 2012) .
The anti-inflammatory potential of some species from Cleomacea family has been demonstrated; however, but some species have only phytochemical studies; for example, from Tarenaya hassleriana Chodat) Iltis (Syn. Cleome hassleriana Chodat) only anthocyanins have been isolated (Jordheim et al., 2009) ; other species with phytochemical potential are C. chrysantha, C. haratensis, C. iberica (Tables 1 and 2 ). In addition, from Cleome rupicola Vicary triterpenes (64) and flavonol glycosides (65) have been isolated with cytotoxic activity on the HeLa cell line (Al-Rehaily et al., 2017) and from C. khorassanica Bunge & Bien. ex Boiss. (aerial parts) dammarane triterpenes (61 and 62) with cytotoxic activity against prostate cell lines (DU-145 and LNCaP) have been described (Sajjadi et al., 2018) .
On the other hand, the essential oils of the C. droserifolia, C. serrata and C. spinosa showed antimicrobial activity against Gram-positive and Gramnegative microoorganisms (Muhaidat et al., 2015; McNeil et al., 2010; ; however, these species have not yet the anti-inflammatory evaluation. Phytol is main component from essential oils of C. burmanni, C. monophylla, Cleoserrata serrata and Tarenaya spinosa, and this diterpene showed a good anti-inflammatory activity by inhibition of the migration of neutrophils, reducing the IL-1β and TNF-α levels and reducing the oxidative stress (Silva et al., 2014) (Table 2) .
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Antinociceptive activity of some genus of Cleomaceae
Pain is a symptom of many chronic degenerative diseases, and their transmission involves the activation of peripheral nociceptors by harmful stimulus that can be sensitized by inflammatory mediators (neuropathic pain mechanisms). Some species of the family Cleomacea have shown analgesic activity.
The main model used for the evaluation of antinociceptive activity is the acetic-acid (a.a.)-induced abdominal constriction test in mice (its model induce visceral inflammation) and this provoke release of endogenous mediators such as bradykinin, serotonin, histamine, substance P and PGE 2 , triggering the activation of peripheral nociceptive neurons (Koster and Anderson, 1959) . Another assay is formalin-induced paw licking test, in which two phases are distinguished, in the first phase (0 to 5 min) the sensitization of the nociceptors (neurogenic pain) is involved and in the second phase (15 to 30 min) an inflammatory process is involved which is triggered by the production of histamine, serotonin, PGE 2 and bradykinin (Hunskaar and Hole, 1987) . Another model is the tail immersion assay, which is a thermal test for evaluating the analgesic potential in warm water (55°C), or tail-flick and hot plate test, which measures the latency time to the thermal stimuli reflecting the central antinociceptive activity (acute pain) (Srinivasan et al., 2003) .
The n-butanol fraction from 80% EtOH extract of Cleome amblyocarpa Barratte & Murb. (Syn. Cleome africana Botsch, medicinal plant is use as analgesic in Rafha city, Northern Border of Saudi Arabia), at 50 mg/kg/i.g via after 60 min showed 80.6% nociceptive activity in the hot plate model and after 90 min its activity was 65.67% and the control diclofenac sodium showed 40% (at 60 min) and 42.8 % (at 90 min) inhibition (El-Wahab et al., 2016) . C. rutidosperma polar extracts has shown central and peripheral analgesia with antiinflammatory activity. The MeOH extract was tested on the mouse models of tail removal and hot plate at doses of 100 and 200 mg/kg/i.g; it showed an increase on the response to thermal stimuli. The extract raised the latency time in the tail-flick test, with 3.11 and 3.22 min, respectively; effect similar to the reference drug morphine (5 mg/kg i.p.) with 4.41 min. In hot plate test at 120 min, the extract (200 mg/kg) showed a response time of 13.22 min (53.52%), this data is very close to morphine with a response time of 15.35 min (67.27%). These results suggest that the antinociceptive effect of the extract is related to opioid receptors. In the abdominal contortion test induced with a.a., extract at 100 and 200 mg/kg/i.g. via inhibited in 39.38 and 47.32%, respectively, the effect was compared to morphine (60.12%). In the paw lick test induced with formalin, in both phases the number of licks was reduced in the early phase 106.0 (19.57%) and 100.6 (23.67%) and in the late phase the number of licks was reduced from 13.40 (85%) and 8.00 (91.30 %) for doses of 100 and 200 mg/kg (Ansari et al., 2016) .
The EtOH extract from C. rutidosperma (aerial parts) showed antinociceptive activity at 200 and 400 mg/kg (administered by i.g.); this extract reduced the number of contortions, being 28.5 and 14.5, respectively, and their diethyl ether fraction at 200 mg/kg also inhibited the contortion number with 14.0 contortions with respect to reference drug (acetylsalicylic acid at 200 mg/kg) with 21.8 contortions. In the tail immersion test, the butanolic fraction (200 mg/kg) induced protection with a reaction time of 7.47 sec, this response time was comparable to refence drug (pentazocine at 30 mg/kg/i.g. via) that showed 8.48 s; therefore, it has been proposed that this activity is due to the fact that this fraction inhibited the prostaglandin production (Bose et al., 2007) .
The analgesic activity in mice was evaluated using the a.a.-induced writhing and the tail flick, tail clip, tail immersion methods; MeOH extract from C. viscosa at 100, 200 and 400 mg/kg/i.g. via showed important activity in all assays (Parimaladevi et al., 2003) . Likewise, the 80% MeOH extract from C. viscosa (leaves) at 250 and 500 mg/kg, administered by i.g, inhibited the number of contortions, with 35.80 and 47.94%, respectively; this effect was comparable to diclofenac sodium, which showed 64.17% inhibition at 25 mg/kg (Bose et al., 2011) . On the other hand, Khanam et al. (2015) described the antinociceptive activity from the MeOH extract, and from chloroform and ethyl acetate fractions, these samples showed 79.16, 81.25 and 70.83% writhing inhibition, respectively. The effect was similar to diclofenac sodium with 83.33% writhing inhibition.
The MeOH extract of leaves and stems from Cleome spinosa (plants obtained in the wild and by biotechnological process) at 50 mg/kg administered by i.p. via showed antinociceptive activity, which was similar to dipyrone (100 mg/kg/s.c., reference drug); in this assay, the stem extract from wild plant was more active with a 68% reduction in the number of contortions (Albarello et al., 2013) .
MeOH extract of the whole plant C. chelidonii at 200 mg/kg showed antinociceptive activity; it decreased the number of contractions to 45.8% compared to the drug aspirin (100 mg/kg/i.g.) with 64.0%, and increased the response to the stimulus in the hot plate test in mouse in a time of 30 min with 13.74 s, in comparison with morphine (5 mg/kg/i.p.) with 17.17 sec (Parimalakrishnan et al., 2007) .
CONCLUSION AND PERSPECTIVES
Four genera of the Cleomaceae family (Cleome, Corynandra, Gynandropsis and Tarenaya) have been described with anti-inflammatory and antinociceptive activities. These genera are widely used in traditional medicine for the treatment of diseases in which there are inflammatory process and pain among other diseases.
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The polar extracts (MeOH or EtOH) prepared from leaves or aerial parts were the most used for the biological tests. Cleome arabica, Corynandra viscosa and Cleome rutidosperma showed a good in vitro and in vivo antiinflammatory activity; in addition, Cleome rutidosperma and Gynandropsis gynandra presented anti-inflammatory effect using in vivo CFA chronic model. Cleome burmanni has only been evaluated in vitro assay and Corynandra chelidonii and Tarenaya spinosa have been evaluated in vivo (carrageenan model). The bioactive compounds from only two species with anti-inflammatory activity have been isolated, from Cleome droserifolia two flavonoids (32 and 33) with anti-inflammatory activity was isolated using peritoneal macrophages (in vitro model). From Corynandra viscosa has been isolated cumarinolignoids [cleomiscosins A, B, C) and quercetin-3-O-(2''-acetyl)glucoside] and these compounds showed a significant anti-inflammatory activity. Respect to antinociceptive activity, acetic-acid-induced abdominal constriction test, hot plate test, tail immersion assays are the most used. To date, only five species: Cleome amblyocarpa, Cleome rutidosperma, Corynandra viscosa, Tarenaya spinosa and Corynandra chelidonnii have been reported with antinociceptive activity. However, to date there are few or no, manuscripts that describe of the bioactive compounds biologically tested of these active species.
It is important to redouble efforts to explore the phytochemistry and pharmacological potential by the Cleomaceae family because some species has an important pharmacological activity but has not yet been isolated the active compounds. On the other hand, it was found that 12 species of the Clemaceae family have phytochemical studies and report the presence of steroids, phenolic acids, anthocyanins, terpenes and alkaloids; however, many of these compounds have not yet been investigated from the pharmacological point of view. Finally, only for 8 species (Cleome burmanni, C. droserifolia, C. heratensis, C. iberica, C. monophylla, Cleoserrata serrata, Corynandra viscosa and Tarenaya spinosa) the chemical composition of essential oils has been described.
Therefore, this family can be a potential source of active compounds that will allow the development of new therapeutic alternatives for the treatment of diseases in which an inflammatory and/or pain process occurs. Based on this review (including chemical and biological research), the species of the Cleomaceae family are a potential source of anti-inflammatory and antinociceptive compounds.
